Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025)

Evaxion A (EVAX) reported Other Accumulated Expenses of $1.2 million for Q2 2025, up 56.5% on a YoY basis from $738000.0 in Q2 2024, and up 24.6% quarter-over-quarter from $927000.0 in Q4 2024.

Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

Evaxion A has reported Other Accumulated Expenses for 6 years, with the latest figure at $1.2 million in Q2 2025.

  • For the quarter ending Q2 2025, Other Accumulated Expenses rose 56.5% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2025 stood at $1.2 million (up 56.5% YoY), and the FY2024 full-year result was $927000.0, down 7.85% from the prior year.
  • Other Accumulated Expenses for Q2 2025 stood at $1.2 million, up from $927000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $3.1 million in Q2 2021, with the low at $665000.0 in Q4 2022.
  • Historically, Other Accumulated Expenses has averaged $1.4 million across 5 years, with a median of $1.0 million in 2021.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses slumped 70.86% — and 2023, when it surged 60.02%.
  • Evaxion A's Other Accumulated Expenses stood at $1.0 million in 2021, then sank by 35.75% to $665000.0 in 2022, then soared by 51.28% to $1.0 million in 2023, then declined by 7.85% to $927000.0 in 2024, then grew by 24.6% to $1.2 million in 2025.
  • The last three Other Accumulated Expenses figures came in at $1.2 million (Q2 2025), $927000.0 (Q4 2024), and $738000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Jun 30, 2025 1.16 Mn
Dec 31, 2024 927,000.00
Jun 30, 2024 738,000.00
Dec 31, 2023 1.01 Mn
Jun 30, 2023 1.49 Mn
Dec 31, 2022 665,000.00
Jun 30, 2022 933,000.00
Mar 31, 2022 744,000.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 2.91 Mn
Jun 30, 2021 3.11 Mn
Mar 31, 2021 2.55 Mn
Dec 31, 2020 2.26 Mn